X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with WYETH LTD - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs WYETH LTD - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA WYETH LTD SANOFI INDIA/
WYETH LTD
 
P/E (TTM) x 33.6 27.7 121.1% View Chart
P/BV x 6.4 5.3 119.6% View Chart
Dividend Yield % 1.4 1.3 110.8%  

Financials

 SANOFI INDIA   WYETH LTD
EQUITY SHARE DATA
    SANOFI INDIA
Dec-16
WYETH LTD
Mar-13
SANOFI INDIA/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs4,5601,044 436.6%   
Low Rs4,400818 537.9%   
Sales per share (Unadj.) Rs1,028.5298.6 344.5%  
Earnings per share (Unadj.) Rs129.057.2 225.3%  
Cash flow per share (Unadj.) Rs186.058.4 318.4%  
Dividends per share (Unadj.) Rs68.0017.00 400.0%  
Dividend yield (eoy) %1.51.8 83.1%  
Book value per share (Unadj.) Rs753.6249.5 302.1%  
Shares outstanding (eoy) m23.0322.72 101.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.43.1 139.7%   
Avg P/E ratio x34.716.3 213.5%  
P/CF ratio (eoy) x24.115.9 151.1%  
Price / Book Value ratio x5.93.7 159.3%  
Dividend payout %52.729.7 177.5%   
Avg Mkt Cap Rs m103,17421,157 487.7%   
No. of employees `0003.60.5 736.4%   
Total wages/salary Rs m3,592400 898.0%   
Avg. sales/employee Rs Th6,537.713,787.4 47.4%   
Avg. wages/employee Rs Th991.4813.0 121.9%   
Avg. net profit/employee Rs Th819.82,643.3 31.0%   
INCOME DATA
Net Sales Rs m23,6866,783 349.2%  
Other income Rs m708353 200.8%   
Total revenues Rs m24,3947,136 341.8%   
Gross profit Rs m5,2811,617 326.5%  
Depreciation Rs m1,31327 4,936.1%   
Interest Rs m156 272.7%   
Profit before tax Rs m4,6611,938 240.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m1,691632 267.5%   
Profit after tax Rs m2,9701,301 228.4%  
Gross profit margin %22.323.8 93.5%  
Effective tax rate %36.332.6 111.2%   
Net profit margin %12.519.2 65.4%  
BALANCE SHEET DATA
Current assets Rs m15,6736,984 224.4%   
Current liabilities Rs m6,6782,056 324.8%   
Net working cap to sales %38.072.6 52.3%  
Current ratio x2.33.4 69.1%  
Inventory Days Days7699 76.6%  
Debtors Days Days2224 93.2%  
Net fixed assets Rs m8,098244 3,314.8%   
Share capital Rs m230227 101.4%   
"Free" reserves Rs m17,0885,441 314.1%   
Net worth Rs m17,3565,668 306.2%   
Long term debt Rs m025 0.0%   
Total assets Rs m25,4007,901 321.5%  
Interest coverage x311.7353.3 88.2%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.90.9 108.6%   
Return on assets %11.816.5 71.1%  
Return on equity %17.122.9 74.6%  
Return on capital %26.934.0 79.1%  
Exports to sales %24.50.2 11,225.3%   
Imports to sales %28.036.3 77.0%   
Exports (fob) Rs m5,80115 39,195.9%   
Imports (cif) Rs m6,6272,465 268.8%   
Fx inflow Rs m7,14515 47,006.6%   
Fx outflow Rs m6,8462,677 255.7%   
Net fx Rs m299-2,662 -11.2%   
CASH FLOW
From Operations Rs m3,226923 349.4%  
From Investments Rs m-1,555317 -490.7%  
From Financial Activity Rs m-1,818-481 378.0%  
Net Cashflow Rs m-147759 -19.4%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 60.4 51.1 118.2%  
Indian inst/Mut Fund % 14.4 11.3 127.4%  
FIIs % 14.6 7.2 202.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 30.4 34.5%  
Shareholders   15,184 21,978 69.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   NATCO PHARMA  PLETHICO PHARMA  WOCKHARDT LTD.  TORRENT PHARMA  FRESENIUS KABI ONCO.  

Compare SANOFI INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Marginally Lower; Energy Stocks Witness Losses(11:30 am)

Share markets in India are presently trading marginally lower. Sectoral indices are trading on a mixed note with stocks in the energy sector and auto sector witnessing maximum selling pressure.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Feb 22, 2018 12:51 PM

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - WYETH LTD COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS